Possibia

209

Last Update Posted: 2005-08-17

Recruiting has ended

All Genders

accepted

21 Years-50 Years

0 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Buprenorphine Dosing Interval - 5

The purpose of this study is to explore the feasibility of extending the dosing interval of well maintained buprenorphine patients to 48 and 72 hours, leading to eventual 3 times/week dosing.

Eligibility

Relevant conditions:

Opioid-Related Disorders

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov